tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BridgeBio Pharma: Buy Rating Backed by Promising Drug Pipeline and Strategic Market Positioning
PremiumRatingsBridgeBio Pharma: Buy Rating Backed by Promising Drug Pipeline and Strategic Market Positioning
12d ago
BridgeBio presents BBO-10203 data at San Antonio Breast Cancer Symposium
Premium
The Fly
BridgeBio presents BBO-10203 data at San Antonio Breast Cancer Symposium
13d ago
BridgeBio price target raised to $84 from $76 at Wells Fargo
Premium
The Fly
BridgeBio price target raised to $84 from $76 at Wells Fargo
1M ago
BridgeBio price target raised to $80 from $66 at Truist
PremiumThe FlyBridgeBio price target raised to $80 from $66 at Truist
2M ago
BridgeBio price target raised to $95 from $60 at TD Cowen
Premium
The Fly
BridgeBio price target raised to $95 from $60 at TD Cowen
2M ago
BridgeBio price target raised to $81 from $73 at Oppenheimer
Premium
The Fly
BridgeBio price target raised to $81 from $73 at Oppenheimer
2M ago
BridgeBio price target raised to $90 from $80 at H.C. Wainwright
PremiumThe FlyBridgeBio price target raised to $90 from $80 at H.C. Wainwright
2M ago
BridgeBio announces Phase 3 study of encaleret met primary endpoint
Premium
The Fly
BridgeBio announces Phase 3 study of encaleret met primary endpoint
2M ago
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
Premium
Ratings
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100